Plotkin's vaccines. ([2024])
- Record Type:
- Book
- Title:
- Plotkin's vaccines. ([2024])
- Main Title:
- Plotkin's vaccines
- Other Titles:
- Vaccines
- Uniform Title:
- Vaccines (Plotkin)
- Further Information:
- Note: [edited by] Walter A. Orenstein, Paul A. Offit, Kathryn M. Edwards, Stanley A. Plotkin.
- Editors:
- Orenstein, Walter A
Offit, Paul A
Edwards, Kathryn M
Plotkin, Stanley A, 1932- - Contents:
- Section 1: General Aspects of Vaccination ; 1 A short history of vaccination; 2 Vaccine immunology; 3 Non-specific effects of Vaccines; 4 Correlates of protection; 5 The vaccine industry; 6 Vaccine manufacturing; 7 Evolution of adjuvants across the centuries; 8 Vaccine Additives and Manufacturing Residuals in Vaccines Licensed in the United States; 9 Passive immunization; Section 2: Licenced Vaccines and Vaccines in Development ; 10 General immunization practices; 11 Human Adenovirus vaccines; 12 Anthrax vaccines; 13 EMERGING Diseases and Emerging VACCINES (Military); 14 Cancer vaccines; 15 Cholera vaccines; 16 Combination vaccines; 17 Coronavirus; 18 Cytomegalovirus vaccines; 19 Dengue vaccines; 20 Diarrhea caused by bacteria; 21 Diphtheria toxoid; 22 Ebola vaccines; 23 Enterovirus; 24 Epstein-Barr virus vaccines; 25 Haemophilus influenzae type b vaccines; 26 Hepatitis A vaccines; 27 Hepatitis B vaccines; 28 Hepatitis C vaccines; 29 Hepatitis E vaccines; 30 Herpes simplex virus vaccines; 31 Human immunodeficiency virus vaccines; 32 Human papillomavirus vaccines; 33 Inactivated influenza vaccines; 34 Influenza vaccine—live; 35 Japanese encephalitis vaccines; 36 Lyme disease vaccines; 37 Malaria vaccines; 38 Measles vaccine; 39 Meningococcal Capsular A, B, C, W, and Y Conjugate Vaccines; 40 Meningococcal Capsular B Vaccines; 41 Mumps vaccines; 42 Noninfectious disease vaccines; 43 Norovirus; 44 Norovirus; 44 Parasitic disease vaccines; 45 Pertussis vaccines; 46 PlagueSection 1: General Aspects of Vaccination ; 1 A short history of vaccination; 2 Vaccine immunology; 3 Non-specific effects of Vaccines; 4 Correlates of protection; 5 The vaccine industry; 6 Vaccine manufacturing; 7 Evolution of adjuvants across the centuries; 8 Vaccine Additives and Manufacturing Residuals in Vaccines Licensed in the United States; 9 Passive immunization; Section 2: Licenced Vaccines and Vaccines in Development ; 10 General immunization practices; 11 Human Adenovirus vaccines; 12 Anthrax vaccines; 13 EMERGING Diseases and Emerging VACCINES (Military); 14 Cancer vaccines; 15 Cholera vaccines; 16 Combination vaccines; 17 Coronavirus; 18 Cytomegalovirus vaccines; 19 Dengue vaccines; 20 Diarrhea caused by bacteria; 21 Diphtheria toxoid; 22 Ebola vaccines; 23 Enterovirus; 24 Epstein-Barr virus vaccines; 25 Haemophilus influenzae type b vaccines; 26 Hepatitis A vaccines; 27 Hepatitis B vaccines; 28 Hepatitis C vaccines; 29 Hepatitis E vaccines; 30 Herpes simplex virus vaccines; 31 Human immunodeficiency virus vaccines; 32 Human papillomavirus vaccines; 33 Inactivated influenza vaccines; 34 Influenza vaccine—live; 35 Japanese encephalitis vaccines; 36 Lyme disease vaccines; 37 Malaria vaccines; 38 Measles vaccine; 39 Meningococcal Capsular A, B, C, W, and Y Conjugate Vaccines; 40 Meningococcal Capsular B Vaccines; 41 Mumps vaccines; 42 Noninfectious disease vaccines; 43 Norovirus; 44 Norovirus; 44 Parasitic disease vaccines; 45 Pertussis vaccines; 46 Plague vaccines; 47 Pneumococcal conjugate vaccine and pneumococcal common protein vaccines; 48 Pneumococcal polysaccharide vaccines; 49 Poliovirus vaccine—inactivated; 50 Poliovirus vaccine—live; 51 Rabies vaccines; 52 Respiratory syncytial virus vaccines; 53 Rotavirus vaccines; 54 Rubella vaccine; 55 Smallpox and vaccinia; 56 Staphylococcus aureus vaccines; 57 Streptococcus group A vaccines; 58 Streptococcus group B vaccines; 59 Tetanus toxoid; 60 Tick-borne encephalitis virus vaccines; 61 Tuberculosis vaccines; 62 Typhoid fever vaccines; 63 Varicella vaccine; 64 Yellow fever vaccine; 65 Zika vaccine; 66 Zoster vaccine; 67 Technologies for making new vaccines; 68 Section 3: New Technologies; 68 The development of gene-based vectors for immunization; 69 Technologies to Improve Immunization; 70 Vaccination of immunocompromised hosts; 71 Section 4: Vaccination in Special Groups; 71 Vaccines for international travel; 72 Vaccines for health care personnel; 73 Vaccination of pregnant women; 74 Vaccination of pregnant women; 74 Immunization in the United States; 75 Immunization in Europe; 76 Section 5: Public Health and Regulatory Issues; 76 Immunization in the Asia-Pacific region; 77 Immunization in developing countries; 78 Community Protection; 79 Economic analyses of vaccine policies; 80 Regulation and testing of vaccines IN THE US; 81 Regulation of vaccines in Europe; 82 Regulation of vaccines in low and middle-income countries; 83 Vaccine safety; 84 Vaccine hesitancy; 85 Legal issues; 86 Ethics; Appendix; Foreword … (more)
- Edition:
- 8th edition
- Publisher Details:
- Philadelphia, PA : Elsevier
- Publication Date:
- 2024
- Copyright Date:
- 2024
- Extent:
- 1 online resource, illustrations (some color), color maps
- Subjects:
- 615.372
Vaccines
Vaccines
Vaccination
Immunization Programs - Languages:
- English
- ISBNs:
- 9780323790598
0323790593 - Related ISBNs:
- 0323790585
9780323790581 - Notes:
- Note: Includes bibliographical references and index.
Note: Online resource; title from table of contents page (Elsevier ClinicalKey, viewed May 31, 2023). - Access Rights:
- Legal Deposit; Only available on premises controlled by the deposit library and to one user at any one time; The Legal Deposit Libraries (Non-Print Works) Regulations (UK).
- Access Usage:
- Restricted: Printing from this resource is governed by The Legal Deposit Libraries (Non-Print Works) Regulations (UK) and UK copyright law currently in force.
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library HMNTS - ELD.DS.753558
- Ingest File:
- 19_005.xml